Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.

Rheumatoid arthritis (RA) has been thought to be largely a T-cell-mediated disease. To evaluate the role of T-cell-independent pathways in RA, we examined the interaction between isolated RA synovial fibroblasts and normal human cartilage engrafted into SCID mice in the absence of T cells and other human cells. The expression of cartilage-de grading enzymes and adhesion molecules was examined by immunohistochemistry and in situ hybridization techniques. The RA synovial fibroblasts invaded the cartilage and kept their transformed appearing cellular shape. They expressed VCAM-1 and produced the cathepsins L and B at the site of invasion. We conclude that RA synovial fibroblasts maintain their invasive and destructive behavior over longer periods of time in the absence of human T cells, indicating that T-cell-independent pathways play a significant role in rheumatoid joint destruction.

[1]  U. Müller-Ladner,et al.  Oncogenes in rheumatoid arthritis. , 1995, Rheumatic diseases clinics of North America.

[2]  J. Kriegsmann,et al.  Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[3]  B. Haynes,et al.  Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. , 1993, Journal of Immunology.

[4]  P. Roughley,et al.  Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. , 1990, The Biochemical journal.

[5]  U. Müller-Ladner T cell-independent cellular pathways of rheumatoid joint destruction. , 1995, Current opinion in rheumatology.

[6]  H. Fassbender,et al.  Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. , 1983, Collagen and related research.

[7]  R. Gay,et al.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? , 1993, Annals of the rheumatic diseases.

[8]  C. Brinckerhoff,et al.  Survival of rheumatoid synovium implanted into nude mice. , 1981, The American journal of pathology.

[9]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis synovium. , 1995, The Journal of clinical investigation.

[10]  J. Kriegsmann,et al.  Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[11]  J. Cesbron,et al.  Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice. , 1994, The Journal of rheumatology.

[12]  J. Kriegsmann,et al.  A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. , 1994, Arthritis and rheumatism.

[13]  R. Gay,et al.  Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[14]  G. Haines,et al.  Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[15]  R. Maciewicz,et al.  Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L , 1990, FEBS letters.

[16]  D. Woolley,et al.  Collagenase at sites of cartilage erosion in the rheumatoid joint. , 1977, Arthritis and rheumatism.

[17]  J. Kriegsmann,et al.  Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. , 1995, Arthritis and rheumatism.

[18]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[19]  K. Kivirikko,et al.  Monoclonal antibodies to human prolyl 4-hydroxylase. , 1984, European journal of biochemistry.

[20]  S. Gay,et al.  Characterization and isolation of poly- and monoclonal antibodies against collagen for use in immunohistochemistry. , 1987, Methods in enzymology.

[21]  G. Firestein,et al.  Pannus and pannocytes , 1994 .

[22]  J. Mcghee,et al.  Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. , 1990, Matrix.

[23]  C. Meijer,et al.  The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. , 1991, Journal of immunology.

[24]  F. Gaeta,et al.  Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. , 1994, The Journal of clinical investigation.

[25]  G. Firestein,et al.  Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. , 1992, The American journal of pathology.

[26]  M. Stephenson,et al.  Mechanisms of Matrix Degradation in Rheumatoid Arthritis a , 1990, Annals of the New York Academy of Sciences.

[27]  K. Kato,et al.  Augmented excretion of procathepsin L of a fos-transferred highly metastatic rat cell line. , 1990, Biochemical and biophysical research communications.

[28]  R. Gay,et al.  Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. , 1994, Journal of immunology.